| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/17/2005 | WO2004046310A3 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 02/17/2005 | WO2004044226A3 Induction of cellular senescence by cdk4 disruption for tumor supression and regression |
| 02/17/2005 | WO2004019115A3 Nanofibers with modified optical properties |
| 02/17/2005 | WO2004019035A3 Method for characterizing biomolecules utilizing a result driven strategy |
| 02/17/2005 | WO2004010850A3 Method for identifying cancer risk |
| 02/17/2005 | WO2004008099A8 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 02/17/2005 | WO2004005457A3 Tfc/ beta-catenin regulated genes for treating cancer |
| 02/17/2005 | WO2004003820A8 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 02/17/2005 | WO2004003223A3 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 02/17/2005 | WO2003102156B1 Heterologous stimulus-gated ion channels and methods of using same |
| 02/17/2005 | WO2003064675A8 Rapid methods and devices for the detection of coliform and the detection and confirmation of e. coli |
| 02/17/2005 | WO2003050258A3 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050039221 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/17/2005 | US20050039220 Labeled coronavirus protein for use as diagnostic tool in detection of viral infection; viricides and vaccine development for treatment and prevention of respiratory system disorders |
| 02/17/2005 | US20050038612 Method for deriving true density of a pharmaceutical solid |
| 02/17/2005 | US20050038609 Evolution-based functional genomics |
| 02/17/2005 | US20050038607 Method for identification pharmacophores |
| 02/17/2005 | US20050038332 System for monitoring physiological characteristics |
| 02/17/2005 | US20050038330 Indwelling glucose sensor; creating nub of dielectric material extending from electrochemical active surface to support membrane system |
| 02/17/2005 | US20050038329 Methods and kits for assays of rapid screening of diabetes |
| 02/17/2005 | US20050038233 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight |
| 02/17/2005 | US20050038113 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease |
| 02/17/2005 | US20050038093 Treating diabetic retinopathy with angiotensin II receptor blockers |
| 02/17/2005 | US20050038039 Formulations |
| 02/17/2005 | US20050037971 Use of hepcidin as a regulator of iron homeostasis |
| 02/17/2005 | US20050037968 Peptide leukotriene receptor |
| 02/17/2005 | US20050037956 Screening method for agents useful in treating diabetes |
| 02/17/2005 | US20050037519 Method of detecting an analyte for lateral flow immunoassay tests |
| 02/17/2005 | US20050037518 Using changes in adrenocorticotropin (ACTH), cortisol, interleukins and endogenous morphine to evaluate efficacy of aerobic exercise; excercise and disease prevention |
| 02/17/2005 | US20050037516 Mass spectrometric analysis using nanoparticles |
| 02/17/2005 | US20050037510 Early determination of assay results |
| 02/17/2005 | US20050037505 Apparatus which utilizes blood protein concentration as diagnostic indicator of blood disorders; bioassay |
| 02/17/2005 | US20050037504 Quantifying cholesterol in high-density lipoproteins in a single step assay using a dry slide; diagnosing cardiovascular disorders |
| 02/17/2005 | US20050037503 Preventing the formation of at least one halogenated volatile organic compound (HVOC) in soil via mixing ice melt compounds with fertilizers; pollution control; groundwater preservation |
| 02/17/2005 | US20050037501 Test kit for simultaneously detecting several types of residues |
| 02/17/2005 | US20050037497 Compounds and methods to enhance rAAV transduction |
| 02/17/2005 | US20050037495 Human CNS cell lines and methods of use therefor |
| 02/17/2005 | US20050037489 Methods of generating human cardiac cells and tissues and uses thereof |
| 02/17/2005 | US20050037476 Modified Wee1, crystals of peptide: inhibitor complexes containing such modified Wee1, and methods of use thereof |
| 02/17/2005 | US20050037464 Prokineticin polypeptides, related compositions and methods |
| 02/17/2005 | US20050037449 Agent for controlling circadian rhythm disorder |
| 02/17/2005 | US20050037448 C-peptide specific assay procedure |
| 02/17/2005 | US20050037447 Protein markers for human benign prostatic hyperplasia (BPH) |
| 02/17/2005 | US20050037446 Protein kinase binding modulator for use in treatment and prevention of cardiovascular, cell proliferative, neurodegenerative and bone disorders |
| 02/17/2005 | US20050037445 analyzing molecules expressed on the cell surface of cancer cells and comparing to nonmalignant cells; screening for cancer specific promoters to be used singly or in combination for delivery and expression of therapeutic genes for treatment of cancer |
| 02/17/2005 | US20050037444 Method for identification isolation and production of antigens to a specific pathogen |
| 02/17/2005 | US20050037443 Detection of sarcocystis neurona |
| 02/17/2005 | US20050037442 Cells transfected with nucleotide sequences that code for mutant mammalian proteins or polypeptides, used for screening antiarrhythmic agents |
| 02/17/2005 | US20050037441 Using presence of complement receptor 1 (CR1) and bound ligand surface of erythrocytes as diagnostic indicator of skin and autoimmune disorders; immunodiagnostics |
| 02/17/2005 | US20050037440 Methods of identifying longevity modulators and therapeutic methods of use thereof |
| 02/17/2005 | US20050037439 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 02/17/2005 | US20050037438 Using probe immobilized cells as tools in identifying modulators for human potassium channels; drug screening and membrane transport; drug delivery and design |
| 02/17/2005 | US20050037437 Identification of antigen by xenogenic, allogenic or autologous antibody-mediated precipitation |
| 02/17/2005 | US20050037436 Test systems and the use thereof for identifying and characterizing compounds |
| 02/17/2005 | US20050037434 Immunolobulin which interferes with lysosome associated membrane protein 1(LAMP-1) ligand binding for use in treatment and prevention of autoimmune diabetes |
| 02/17/2005 | US20050037433 Using N-methyl-D-aspartate (NMDA) receptor to identify modulators for treatment and prevention of neurodegenerative diseases |
| 02/17/2005 | US20050037432 Macroglobulin peptides for use as diagnostic indicator of osteoarthritis, bone and tissue disorders |
| 02/17/2005 | US20050037431 Methods and compositions for modulating HGF/Met |
| 02/17/2005 | US20050037429 microarrays comprising solid supports, used for high throughput assays or screening |
| 02/17/2005 | US20050037428 Artificial receptors including reversibly immobilized building blocks, the building blocks, and methods |
| 02/17/2005 | US20050037424 Microfluidic apparatus comprising flexible substrate for use in gene expression analysis; diagnosing viral, cell proliferative, blood, respiratory and muscular disorders |
| 02/17/2005 | US20050037419 Compositions and methods relating to lung specific genes and proteins |
| 02/17/2005 | US20050037418 Method and apparatus for assaying a drug candidate to estimate a pharmacokinetic parameter associated therewith |
| 02/17/2005 | US20050037417 Screening peptide library for amino acid sequences which specifically target/hybridize to brain and kidney tissue; immunodiagnostics; tissue targeted therapy |
| 02/17/2005 | US20050037416 Hybrid nucleic acid; isolation antibody |
| 02/17/2005 | US20050037415 Using transgenic cells as tools in identifying therapeutic amino acids; mimetic peptides; drug screening |
| 02/17/2005 | US20050037413 functionalized substrates bound to layers of dendrimers and to target-specific ligands, used in combinatorial chemistry, protein, nucleic acid or nucleic acid/peptide hybridization detection; medical diagnosis |
| 02/17/2005 | US20050037410 Detection format for hot start real time polymerase chain reaction |
| 02/17/2005 | US20050037409 Identifying and quantifying fusion protein comprising translocating markers that are responsive to altered cellular conditions; detecting vector transformed cell |
| 02/17/2005 | US20050037407 Using microfluidic support comprising receptor immobilized electronic detection matrix for detection, biosynthesis, analysis and quantification of biopolmer sequences |
| 02/17/2005 | US20050037406 Using fluorescent microscopy to detect, quantify and characterize cells associated with cell proliferative disorders; image diagnostics and cancer detection |
| 02/17/2005 | US20050037404 Methods of modulating drug clearance mechanisms by altering SXR activity |
| 02/17/2005 | US20050037402 Device and process for direct quantitative in vitro determination of a substance that is contained in a sample |
| 02/17/2005 | US20050037400 Identifying non-human primate genomic sequences associated with enhanced protection from viral infection viral; enhancing resistance lymphadenopathy associated viral infection |
| 02/17/2005 | US20050037399 nucleic acid having a specific nucleotide sequence, used to diagnose or determine predisposition to adenocarcinoma. |
| 02/17/2005 | US20050037392 Optical sorting method |
| 02/17/2005 | US20050037391 Polypeptide |
| 02/17/2005 | US20050037390 Exposing transgenic cell comprising vectors which contain erythropoietin regulator sequences and reporter molecules to erythropoietin modulating protein, monitoring gene expression; identifying agents for treatment of blood disorders |
| 02/17/2005 | US20050037386 Composition and processes for analysis of pharmacologic agents in biological samples |
| 02/17/2005 | US20050037382 Methods and compositions for treating and preventing autoimmune disorders |
| 02/17/2005 | US20050037377 Detection of binding factors with fluorescence polarization |
| 02/17/2005 | US20050037375 Using ligand-receptor interactions as tool to monitor effectiveness of modulators in disease treatment which act via receptor binding; drug screening and design |
| 02/17/2005 | US20050037374 uses nanoparticle-based assemblies, which comprise a nanoparticle, a surrogate marker and detectors; efficient and accurate means for diagnosing a condition, disease, or disorder and for focused treatment regimens; for identifying the presence of a target analyte/biomarker in a sample of bodily fluids |
| 02/17/2005 | US20050037371 Computer hybridization analysis of preferential gene sequences; genomics |
| 02/17/2005 | US20050037369 Using cell surface and lymphocyte receptors to identify modulator for use in treatment and prevention of graft rejection and cell proliferative disorders; peptide mimetics; imaging diagnostics |
| 02/17/2005 | US20050037366 Individual drug safety |
| 02/17/2005 | US20050037365 Arrays for multiplexed surface plasmon resonance detection of biological molecules |
| 02/17/2005 | US20050037364 Techniques for recording signals |
| 02/17/2005 | US20050037363 Methods and system for multi-drug treatment discovery |
| 02/17/2005 | US20050037362 Using microarray hybridization to quantify and analyze RNA interference; detection, identification and/or quantification of multiple gene-specific short interfering RNA sequences |
| 02/17/2005 | US20050037361 Kit comprising betaine and sorbitol additives for use in decreasing stalling during replication of mononucleotide, dinucleotide, tetranucleotide and pentanucleotide microsatellite sequences; genotyping |
| 02/17/2005 | US20050037359 Differentiating and identifying polynucleotides and/or polypeptides via binding to large scale integrated circuit (LSI); non-radioacitve labeling of biopolymers |
| 02/17/2005 | US20050037357 Matrix comprising immobilized polynucleotide probes for use in determining translation efficiency of messenger RNA variants and monitor accuracy gene expression in cells |
| 02/17/2005 | US20050037354 Method for epigenetic knowledge generation |
| 02/17/2005 | US20050037353 Highly sensitive methods for protein detection in proteomics |
| 02/17/2005 | US20050037343 Three dimensional format biochips |
| 02/17/2005 | US20050037342 Methods for determining risk of developing cervical cancer |
| 02/17/2005 | US20050037341 Method of monitoring a biological system by labeling with an apo metal binding protein |